Molecular Testing For The Management Of Pancreatic Cysts, Barrett Esophagus, And Solid Pancreaticobiliary Lesions

Tests that integrate microscopic analysis with molecular tissue analysis are generally called topographic genotyping. Interpace Diagnostics offers 2 such tests that use the PathFinderTG® platform (PancraGEN® ). These molecular tests are intended to be used adjunctively when a definitive pathologic diagnosis cannot be made, because of the inadequate specimen or equivocal histologic or cytologic findings, to inform appropriate surveillance or surgical strategies.